Citalopram Price in Washington
Compare cash-pay prices for Citalopram (Citalopram Hydrobromide) from verified pharmacies across Washington. No insurance required.
Washington Median
$3
per month
National Average
$20
per month
Your Savings
85%
below national avg
Pharmacies in Top Washington Cities
Progressive pharmacy market with strong price competition, especially in the Seattle metro.
Seattle
Citalopram pharmacies
Spokane
Citalopram pharmacies
Tacoma
Citalopram pharmacies
Vancouver
Citalopram pharmacies
Bellevue
Citalopram pharmacies
Citalopram in Washington: Frequently Asked Questions
How much does Citalopram cost in Washington?
The median cash-pay price for Citalopram in Washington is approximately $3. Prices range from $2 to $4 depending on the pharmacy, dosage, and quantity. This is 85% below the national average of $20.
Do I need insurance to buy Citalopram in Washington?
No. You can purchase Citalopram at cash-pay prices from any licensed pharmacy in Washington without insurance. Script Unlock helps you compare cash-pay bids from verified pharmacies to find the lowest price.
Which pharmacies in Washington offer the best Citalopram prices?
Prices vary significantly between pharmacies. Independent pharmacies and compounding pharmacies in Seattle and Spokane often offer competitive cash-pay pricing. Upload your prescription to Script Unlock to compare live bids from verified Washington pharmacies.
Can I get Citalopram delivered in Washington?
Yes. Many pharmacies in Washington offer mail-order delivery for Citalopram. Some pharmacies also offer free local delivery in metro areas like Seattle. Check with each pharmacy when comparing bids on Script Unlock.
Are there generic alternatives to Citalopram available in Washington?
Yes, the generic version (Citalopram Hydrobromide) is available at most Washington pharmacies and is typically 50-80% cheaper than the brand name. Washington state has a Prescription Drug Affordability Board reviewing high-cost medications.
Washington Pharmacy Regulation: Washington state has a Prescription Drug Affordability Board reviewing high-cost medications.